Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients

Open Access

Peer-reviewed

Research Article

Kathan Mehta,

Affiliation University of Pittsburgh Medical Center, Pittsburgh, PA, United States of America
⨯
Leonard Appleman,

Affiliation University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States of America
⨯
Hong Wang,

Affiliation University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States of America
⨯
Ahmad A. Tarhini,

Affiliation University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States of America
⨯
Rahul A. Parikh

* E-mail: parikhr@upmc.edu

Affiliation University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States of America
⨯

Reader Comments (0)

Melanoma
Is the Subject Area "Melanoma" applicable to this article?

Thanks for your feedback.
Renal cell carcinoma
Is the Subject Area "Renal cell carcinoma" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Inpatients
Is the Subject Area "Inpatients" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Hospitals
Is the Subject Area "Hospitals" applicable to this article?

Thanks for your feedback.
Skin tumors
Is the Subject Area "Skin tumors" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.